Biodegradable, Biocompatible Pressure Sensitive Adhesives
可生物降解、生物相容性压敏粘合剂
基本信息
- 批准号:10677869
- 负责人:
- 金额:$ 52.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-05 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AcrylatesAdherenceAdhesionsAdhesivesAirAir MovementsAlveolarBacteriaBacterial InfectionsBandageBenignBiocompatible MaterialsBronchial InjuryBypassCarbon DioxideCarbonatesCessation of lifeChemical StructureClinicalCollaborationsCollagenDataDuct (organ) structureEndotheliumEpitheliumEthanolEvaluationExcisionExhibitsExperimental DesignsFamily suidaeFibroblastsFistulaFormulationGlassGlyceric AcidsGlycerolGuidelinesHealth Care CostsHumanHydrophobicityIn VitroInfectionInjuryLibrariesLiquid substanceLungMacrophageMedicalMedical Device SafetyMetalsModelingMolecular WeightMorbidity - disease rateMusMuscleOligonucleotidesOperative Surgical ProceduresOralPaperPatient CarePerformancePleuralPleural cavityPolymersPreventionProceduresPropertyPulmonary valve structureRespirationRespiratory physiologySecureSeriesSteelStructureStructure of parenchyma of lungSurfaceSurgical StaplersSurgical suturesTestingThoracic Surgical ProceduresTissuesWood materialbiocompatible polymerbiomaterial compatibilitycancer invasivenesscomparativecytotoxicityethylene glycolexperimental studyfunctional mimicshealingimplantationimprovedin vivoin vivo Modelinnovative technologieslung injurymechanical behaviormigrationmortalitynovelorgan injurypoly(lactide)polyacrylateporcine modelpressurepreventrepairedresponsesealsealantwound
项目摘要
PROJECT SUMMARY/ABSTRACT
* This proposal describes new biodegradable, biocompatible pressure sensitive adhesives (PSAs) with
tunable adhesion strength for in vivo use. Thus, this innovative technology overcomes the limitation of current
PSAs which are only used topically and broadens the scope of applications of such biomaterials in patient care.
To highlight the utility of these new PSAs, we identified two significant and problematic clinical procedures in
thoracic surgery associated with increases in health care costs and high mortality rates: the repair of alveolar-
and broncho- pleural fistulae. Today, closure of such leaks is challenging due to use in a contained space and
to an inherent pressure gradient across the fistula. Survival is directly related to successful fistula closure and
prevention of pleural infection through the fistula. Specifically, we are evaluating novel poly(1,2-glyceric acid
carbonate)s and poly(1,2-glycerol carbonate)s (PGCs) which functionally mimic conventional polyacrylate PSAs
but possess biodegradable carbonate linkages and degrade into benign products – e.g., glycerol, CO2, ethanol.
These first-of-their-kind polymers provide an opportunity to create a new class of PSAs and shift the paradigm
around our ability to control and manage intrathoracic wounds. The proposed experiments will test the hy-
potheses that these PGC based pressure sensitive adhesives will: 1) exhibit compositionally dependent
adhesive strength which positively correlates with greater molecular weight, longer alkyl chains, and
stereoregularity; 2) display peel strengths which can be tuned over a wide range from Post-it® note to
Duct® Tape like performance; and, 3) enable securing a collagen buttress to a surgical stapler or an
electrospun polylactide mesh patch for sealing lung and bronchial injuries. Importantly, preliminary data
support these hypotheses, and well-characterized materials and rigorous experimental designs are established
in this proposal with essential cross-disciplinary collaborations and expertise. The specific aims of this five-year
proposal are: Aim 1. Synthesize and characterize a series of PGC-based pressure sensitive adhesives; Aim 2.
Evaluate the compatibility of the PGC-adhesive collagen and PLA patch in vitro and in vivo, and inhibition of
bacteria migration in vitro; and, Aim 3. Evaluate the performance of the PGC-adhesive collagen and PLA patch
in an in vivo porcine model.
项目总结/摘要
* 该提案描述了新的可生物降解的、生物相容的压敏粘合剂(PSA),
用于体内使用的可调粘附强度。因此,这种创新技术克服了电流的限制,
PSA仅局部使用,扩大了此类生物材料在患者护理中的应用范围。
为了突出这些新PSA的效用,我们确定了两个重要的和有问题的临床程序,
胸外科手术与医疗保健费用增加和高死亡率相关:修复肺泡-
和支气管胸膜瘘如今,由于在封闭空间中使用,
瘘管内的压力梯度存活率与瘘管成功闭合直接相关,
预防胸膜感染通过瘘。具体来说,我们正在评估新的聚(1,2-甘油酸
聚碳酸酯)和聚(1,2-甘油碳酸酯)(PGCs),其在功能上模拟常规聚丙烯酸酯PSA
但具有可生物降解的碳酸酯键并降解成良性产物-例如,甘油二氧化碳乙醇
这些第一种聚合物提供了一个机会,创造一个新的公益广告类和改变范式
我们控制和处理胸内伤口的能力。这些实验将测试hy-
这些基于PGC的压敏粘合剂将:1)表现出组成依赖性,
粘合强度与较大的分子量、较长的烷基链和
立构规整性; 2)显示出剥离强度,其可以在从便利贴到
Duct®胶带般的性能;以及,3)能够将胶原蛋白支撑物固定到外科吻合器或
用于密封肺和支气管损伤的电纺聚乳酸网状补片。重要的是,初步数据
支持这些假设,并建立了良好的表征材料和严格的实验设计
在这项提案中,我们需要必要的跨学科合作和专业知识。这五年的具体目标
建议是:目标1。合成并表征一系列PGC基压敏胶;目的2.
评价PGC粘附性胶原蛋白和PLA贴片的体外和体内相容性以及对
体外细菌迁移;和,目的3.评价PGC-粘性胶原蛋白和PLA补片的性能
在体内猪模型中。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yolonda L Colson其他文献
Yolonda L Colson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yolonda L Colson', 18)}}的其他基金
Biodegradable, Biocompatible Pressure Sensitive Adhesives
可生物降解、生物相容性压敏粘合剂
- 批准号:
10442908 - 财政年份:2022
- 资助金额:
$ 52.05万 - 项目类别:
Supratherapeutic PTX Buttresses Reduce Locoregional Recurrence Rates Following Surgery for Soft Tissue Sarcomas
超治疗 PTX 支撑可降低软组织肉瘤手术后的局部复发率
- 批准号:
10670441 - 财政年份:2022
- 资助金额:
$ 52.05万 - 项目类别:
Precise tumor targeting with logic CAR circuits
利用逻辑 CAR 电路精确肿瘤靶向
- 批准号:
10330301 - 财政年份:2021
- 资助金额:
$ 52.05万 - 项目类别:
Precise tumor targeting with logic CAR circuits
利用逻辑 CAR 电路精确肿瘤靶向
- 批准号:
10490410 - 财政年份:2021
- 资助金额:
$ 52.05万 - 项目类别:
SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNGTUMOR RECURRENCE
用于预防肺部肿瘤复发的超疏水载药支撑
- 批准号:
10331020 - 财政年份:2019
- 资助金额:
$ 52.05万 - 项目类别:
SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNG TUMOR RECURRENCE
用于预防肺肿瘤复发的超疏水载药支撑
- 批准号:
10083724 - 财政年份:2019
- 资助金额:
$ 52.05万 - 项目类别:
OPTIMIZATION OF NANOPARTICLE TUMOR-LOCALIZATION AND DRUG-LOADING FOR TREATING MESOTHELIOMA
优化纳米颗粒肿瘤定位和载药治疗间皮瘤
- 批准号:
10083718 - 财政年份:2019
- 资助金额:
$ 52.05万 - 项目类别:
OPTIMIZATION OF NANOPARTICLE TUMOR-LOCALIZATION AND DRUG-LOADINGFOR TREATING MESOTHELIOMA
用于治疗间皮瘤的纳米颗粒肿瘤定位和载药优化
- 批准号:
10330568 - 财政年份:2019
- 资助金额:
$ 52.05万 - 项目类别:
SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNGTUMOR RECURRENCE
用于预防肺部肿瘤复发的超疏水载药支撑
- 批准号:
10553156 - 财政年份:2019
- 资助金额:
$ 52.05万 - 项目类别:
OPTIMIZATION OF NANOPARTICLE TUMOR-LOCALIZATION AND DRUG-LOADINGFOR TREATING MESOTHELIOMA
用于治疗间皮瘤的纳米颗粒肿瘤定位和载药优化
- 批准号:
10551854 - 财政年份:2019
- 资助金额:
$ 52.05万 - 项目类别:
相似海外基金
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 52.05万 - 项目类别:
Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 52.05万 - 项目类别:
Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 52.05万 - 项目类别:
Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 52.05万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 52.05万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 52.05万 - 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 52.05万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 52.05万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 52.05万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 52.05万 - 项目类别:
Fellowship Programs